~~<i id='FD7B27F1B1'><strike id='FD7B27F1B1'><tt id='FD7B27F1B1'><pre id='FD7B27F1B1'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

author：fashion 2025-09-29 22:50:30 - browse：9

In this photo illustration, Farxiga, Xarelto, Entresto, and Eliquis are made available to customers at the New City Halsted Pharmacy on August 29, 2023 in Chicago, Illinois. These are 4 of 10 prescription drugs that will be subject to Medicare price negotiations under the Inflation Reduction Act. The other drugs include Jardiance, Enbrel, Januvia, Imbruvica, Stelara and Fiasp. — Scott Olson/Getty Images

WASHINGTON — The Biden administration is making its opening offers to pharmaceutical companies in its brand-new Medicare drug price negotiation program on Thursday, administration officials said. And that’s about all they said.

The offers will not be made public unless a manufacturer chooses to publicly disclose information about the talks, a senior administration official said. Companies have until March 2 to either accept the government’s offer or propose a counteroffer. The Biden administration will publish the final prices by Sept. 1 of this year after the negotiation process ends.

The negotiated prices won’t take effect until 2026.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： DeSantis talks Trump, trans issues and 'what wokeness is'

hotspot

focus

Wikipedia

hotspot

leisure time

hotspot

Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

WSS

Tori Bowie and the unacceptable rates of Black maternal death

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

Tocagen's brain cancer gene therapy trial continues. Investors worry

Bright Health sells Medicare Advantage business to Molina

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

focus

focus

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

New air purifier tech could be key to improving indoor air quality

In Memoriam: Notable people who died in 2023

I learned firsthand about improving diversity in clinical trials

Cancer drug shortages should be causing more outrage

As demand for Covid shots wanes, Moderna seeks its next success

Sports medicine is finally prioritizing gender equality

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

focus

Hospitals struggle to profit from CAR

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

Walensky prepares to leave CDC — and Congress — behind

Mass General totes up its waste in a move to tackle climate change

After affirmative action ruling, medical educators look to 'holistic review'

Winning ticket for $1 billion Powerball jackpot sold in California

Wikipedia

hotspot

leisure time

hotspot